Original articleDriving Cessation and Driving Limitation in Glaucoma: The Salisbury Eye Evaluation Project
Section snippets
Patients and Methods
The Johns Hopkins Institutional Review Board approved the protocols for all 4 study rounds of the SEE. Data collection for round 1 began in 1993, and data from the fourth and final round were collected between August 2001 and July 2003 (Fig 1). All subjects gave written informed consent before participation. Detailed methods of subject enrollment were described previously.13, 14
Results
One thousand two hundred fifty-three subjects participated in the SEE through round 4. Because glaucoma status was determined only during the fourth round of the study, only those who continued to participate through round 4 were included in this analysis. Ninety-four subjects were excluded after reporting that they had never driven a car, including 4.8% of subjects without glaucoma, 6.6% of subjects with unilateral glaucoma, and 6.8% of subjects with bilateral glaucoma (P>0.4 when comparing
Discussion
In older residents of the Eastern Shore of Maryland, bilateral glaucoma was a strong risk factor for driving cessation, conferring a risk nearly as great as female gender or a substantial drop in cognition (Table 4). Driving cessation was associated most strongly with bilateral glaucoma during the 2-year period immediately preceding the glaucoma evaluation, and unilateral glaucoma also demonstrated an association with driving cessation during this period. Glaucoma was not associated with more
References (36)
- et al.
Glaucoma and quality of life: the Salisbury Eye Evaluation
Ophthalmology
(2008) - et al.
Who participates in population based studies of visual impairment?The Salisbury Eye Evaluation Project experience
Ann Epidemiol
(1999) - et al.
“Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician
J Psychiatr Res
(1975) - et al.
Impact of an educational program on the safety of high-risk, visually impaired, older drivers
Am J Prev Med
(2004) - et al.
Identifying crash involvement among older drivers: agreement between self-report and state records
Accid Anal Prev
(1998) - et al.
Crash risks of older drivers: a panel data analysis
Accid Anal Prev
(1998) Prevalence of open-angle glaucoma among adults in the United States
Arch Ophthalmol
(2004)Glaucoma and disability: which tasks are affected, and at what stage of disease?
Curr Opin Ophthalmol
(2009)- et al.
The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: Proyecto VER
Invest Ophthalmol Vis Sci
(2002) - et al.
Influence of glaucomatous visual field loss on health-related quality of life
Arch Ophthalmol
(1997)
Risk of falls and motor vehicle collisions in glaucoma
Invest Ophthalmol Vis Sci
Visual field defects and the risk of motor vehicle collisions among patients with glaucoma
Invest Ophthalmol Vis Sci
Driving is transportation for most older adults
Geriatrics
Driving cessation and increased depressive symptoms: prospective evidence from the New Haven EPESE
J Am Geriatr Soc
Driving status and risk of entry into long-term care in older adults
Am J Public Health
Measures of visual function and their association with driving modification in older adults
Invest Ophthalmol Vis Sci
Sources of binocular suprathreshold visual field loss in a cohort of older women being followed for risk of falls (an American Ophthalmological Society thesis)
Trans Am Ophthalmol Soc
A comprehensive assessment of visual impairment in a population of older Americans: the SEE StudySalisbury Eye Evaluation Project
Invest Ophthalmol Vis Sci
Cited by (122)
Glaucoma: now and beyond
2023, The LancetProgressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
2023, American Journal of OphthalmologyFive-Year Visual Field Outcomes of the HORIZON Trial
2023, American Journal of OphthalmologyVision, attention, and driving
2021, Handbook of Clinical Neurology
Manuscript no. 2008-1387.
Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Supported by the National Institutes of Health, Bethesda, Maryland (grant nos.: EY01765, AG10184, EY015025). The funding organization had no role in the design or conduct of this research.